The Female Health Company manufactures, markets and sells the FC2 Female Condom.  FC2 is the only female-controlled product approved by the U.S. Food and Drug Administration (FDA) and cleared by the World Health Organization (WHO) that provides dual protection against unintended pregnancy and sexually transmitted infections (STI’s), including HIV/AIDS. For sexually active couples, male and female condoms are the only two FDA approved and marketed products that prevent the transmission of HIV/AIDS through sexual intercourse.  HIV/AIDS remains the leading cause of death worldwide amount women 15-44 years of age.  More than 50% of new HIV infections are women and 80% of infections are the result of heterosexual sex.

The Company’s customers are primarily large global agencies, non-government organizations, ministries of health and other government agencies which purchase and distribute FC2 for use in HIV/AIDS prevention and family planning programs. Since the Company began distributing FC2 in 2007, it has been shipped to 144 countries world-wide. The Company’s customer base consists primarily of a small number of customers who purchase large quantities. Due to the receipt and timing of large orders, the Company experiences some quarter to quarter fluctuation in unit sales.

The Female Health Company’s headquarters are located in Chicago, Illinois.  The Company has an office located in London, England and a manufacturing facility located in Selangor D.E., Malaysia.

The Female Health Company’s Medical Advisory Board Members